Simplify Logo

Full-Time

Lead – Corporate Communications

Confirmed live in the last 24 hours

Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

201-500 employees

Develops treatments for neurodegenerative diseases

Social Impact
Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Category
Public Health
Biology & Biotech
Requirements
  • Bachelor’s degree
  • 10+ years of relevant work experience, with 5+ years of previous healthcare/pharma/biotech industry experience
  • Exceptional verbal, written, and presentation skills, with the ability to effectively tailor communication to a broad collection of external and internal audiences
  • Ability to translate complex scientific, clinical, and financial data into easy to communicate messaging
  • Exceptional attention to detail and ability to multi-task in a fast-paced, high-pressure, deadline driven environment
  • Ability to adapt quickly, an energetic, efficient, and resourceful team player and individual contributor
  • An active and effective leader
  • A person with an insatiable appetite to learn more
  • Ability to travel up to 20% if not local to the Boston area
Responsibilities
  • Lead public relations plans and initiatives to drive key message penetration in media coverage, extend company awareness, and support Amylyx’ vision and goals
  • Lead development of executive thought leadership strategy
  • Develop press releases, media statements, key message documents, presentations, and other supporting materials; streamline and shepherd cross-functional review processes
  • Ensure strong collaboration and scenario-planning across key functions to strategically elevate company milestones
  • Build reporting and metrics to measure impact of PR/comms efforts and report impact to functional heads and executive leadership
  • Help cultivate relationships with key media stakeholders, including journalists, bloggers, and relevant influencers
  • Ensure excellence in media and communications materials, including development, writing, style, tone, approval: video scripts and final cuts, subscriber emails, flyers, media fact sheets, message documents, Q&As, brochures and related media materials
  • Support development of effective media pitches, identify leads, manage logistics, and provide talking points for senior management media opportunities
  • Oversee monitoring of industry news, creation and maintenance of media lists, conducting of media outreach campaigns, and providing of rapid responses to incoming media requests for interviews; identify proactive and reactive opportunities to maximize editorial placement
  • Assist in developing strategic external communications plans for crisis management; carefully manage execution
  • Train employees in media engagement policy as appropriate
  • Support the corporate communications team’s integrated, global social media strategy that further establishes Amylyx as an industry leader, including helping write and post social content aligned with Amylyx messaging and assisting with social media community management
  • Assist with efforts to activate employees through social and digital programs and activities
  • Drive announcement-related website changes across main corporate and investor sites; provide input on other website content as needed (e.g., clinical trial sites, future disease awareness or advocacy websites)
  • Develop subscriber email blasts to amplify company announcements
  • Contribute to internal communications strategy promoting employee engagement and inclusivity
  • Distill external corporate communications and investor relations announcements for an internal audience and draft executive talking points
  • Provide recommendations to leadership on how to internally communicate complex or challenging topics
  • Introduce new processes and tools to incorporate employee feedback and generate excitement for our R&D programs (e.g., surveys to name clinical trials and collect team achievements for end of year recap)
  • Develop employee spotlight strategy and conduct interviews to write articles for intranet and social media as appropriate
  • Recommend updates to optimize intranet (“Lynx”) experience; oversee implementation of those and all other requested Lynx updates
  • Track reporting and metrics to measure impact
Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

View

Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, focusing on conditions like Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease (ALZ). Their main product, AMX0035, is currently undergoing clinical trials to assess its effectiveness. The CENTAUR ALS trial showed promising results for ALS patients, using a randomized, double-blind, placebo-controlled design to ensure reliable outcomes. They are also conducting the PEGASUS trial to evaluate AMX0035's safety and effectiveness in Alzheimer's patients. Unlike many competitors, Amylyx emphasizes community engagement and awareness campaigns, such as ALS Awareness Month, to educate the public and foster support for those affected by these diseases. The company's goal is to bring effective therapies to market that improve patient outcomes.

Company Stage

IPO

Total Funding

$548.9M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

-5%

1 year growth

8%

2 year growth

58%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful acquisition of Phase 3-ready avexitide from Eiger could diversify Amylyx's pipeline and open new revenue streams.
  • Interim data from the Phase 2 HELIOS trial shows promising results for AMX0035 in treating Wolfram syndrome, indicating potential for broader applications.
  • The appointment of experienced professionals like Dr. Bernhardt Zeiher to the Board of Directors strengthens the company's leadership and strategic direction.

What critics are saying

  • The failure of the Phase III PHOENIX trial and subsequent market withdrawal of Relyvrio raises concerns about the efficacy of Amylyx's treatments.
  • A significant workforce reduction by 70% under a restructuring plan could impact company morale and operational efficiency.

What makes Amylyx Pharmaceuticals unique

  • Amylyx Pharmaceuticals focuses on neurodegenerative diseases like ALS and Alzheimer's, setting it apart from competitors with broader therapeutic areas.
  • The company's flagship product, AMX0035, has shown significant treatment benefits in rigorous clinical trials, including the CENTAUR ALS trial, which is a strong validation of its efficacy.
  • Amylyx's commitment to community engagement and awareness campaigns, such as ALS Awareness Month, enhances its brand and builds a supportive community around its cause.